[Clinical and social problems in controlling multidrug-resistant organisms].
There have been limited evidence for controlling multidrug-resistant Gram negative bacilli, since multidrug-resistant Pseudomonas aeruginosa (MDRP) and multidrug-resistant Acinetobacter baumannii (MDR-Ab) have emerged. The Center for Disease Control and Prevention (CDC) has published the first guideline entitled 'Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006'. Following that, the Association for Professionals in Infection Control and Epidemiology (APIC) has also published a guidance entitled 'Guide to the Elimination of Multidrug-resistant Acinetobacter baumannii Transmission in Healthcare Settings' in 2010. The Japanese Society for Environmental Infections (JSEI) has launched soon after the largest MDR-Ab outbreak was reported, and then published the position statement on controlling multidrug-resistant organisms. The aim of this statement is to provide a clear direction of controlling multidrug-resistant Gram negative bacilli to Japanese healthcare facilities, when planning a grand design of infection control in each setting. In this report, critical points and matters need to be discussed were assessed.